We improve research and reduce risks at all stages of development.

Cell and Gene Therapy

As a trailblazer in the industry, Noble helps you navigate the challenges unique to cell and gene therapies. Our experienced team is ready to guide you through the continuously evolving high-standards, challenges, and changes you’ll face in the cell and gene therapy industry.

We improve research and reduce risks at all stages of development.

Cell and Gene Therapy

As a trailblazer in the industry, Noble helps you navigate the challenges unique to cell and gene therapies. Our experienced team of experts is ready to guide you to face high-standards challenges and the continuous evolution of the clinical and regulatory industry.

Cell and Gene Therapy

We improve research and reduce risks at all stages of development.

As a trailblazer in the industry, Noble helps you navigate the challenges unique to cell and gene therapies. Our experienced team is ready to guide you through the continuously evolving high-standards, challenges, and changes you’ll face in the cell and gene therapy industry.

Biodistribution & Shedding

Biodistribution & Shedding

Assessment of the infection risks with the viral vector in the patient environment.

Toxicology

Toxicology

Assistance for planning and executing preclinical studies and IND submissions.

Efficacy

Efficacy

End-to-end program to connect each phase of your cell & gene therapy journey.

Immunoassays

Immunoassays

Management of complexity and processes for the long assay development time.

Flow Cytometry

Flow Cytometry

Testing service laboratories optimized for simultaneity, speed and large scale capacity.

Proof-of-Concept Studies

Cell and Gene Therapy CRO Services

Our team of experts will help develop assays to ease the research path, obtain FDA authorizations, and understand the importance of clinical strategy, protocol design, and feasibility.

From protocol design to data management, our best practices in managing therapies will guide you to develop the Proof-of-concept of your cell and gene therapy product.

Cell & Gene Therapeutic Research

3 Strategies to Use When Selecting a CRO For a Gene Therapy Study

  1. Do your due diligence when researching each CRO for your cell-gene therapy study
  2. Look for robust assay and model development experience
  3. Anticipate the challenges associated with cell-gene therapy studies

Cell and Gene Therapy IND Enabling Studies

Generate IND ready data for your FDA submission

Quality and Regulatory support

Hybrid pharmacology/ toxicity/ activity studies

  • Pharmacodynamic marker analysis
  • Local and systemic toxicity
  • Histopathology

Inflammatory/immune response

  • Blood cytokine analysis
  • Immune system cellular response

Cell product characterization

  • Insertion site analysis
  • Transgene characterization

Biodistribution location and persistence of the product

  • Real time PCR
  • Flow Cytometry
  • Animal imaging

Cell & Gene Therapy

Access unparalleled scientific, operational, and regulatory solutions across the entire cell and gene therapy development continuum—right from the start.

Resources & White Papers

PASSIONATE ABOUT COLLABORATING FOR A CURE

Mouse Peritonitis/Sepsis Model of MRSA Infection

Mouse Peritonitis/Sepsis Model of MRSA Infection

Noble Life Sciences, in collaboration with ImQuest Biosciences, has optimized the peritonitis/sepsis mouse model to screen for new antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA). The model’s popularity derives from its ease of use with small and expensive animals, short-duration experiments with reproducible infections, and simple end-points.

read more